文献速递焦虑、强迫与应激相关障碍会诊联络精神医学

未用药强迫症患者肠道菌群经琥珀酸驱动小鼠行为症状与神经炎症

Human microbiota from drug-naive patients with obsessive-compulsive disorder drives behavioral symptoms and neuroinflammation via succinic acid in mice.
PubMed 文献 · Mol Psychiatry · 2024-01-25

该研究将首发未用药强迫症患者或人口学匹配健康人的粪便菌群移植给抗生素处理的SPF小鼠,发现强迫症菌群足以诱导焦虑样和强迫样行为缺陷。16S rRNA测序显示两组小鼠粪便菌群明显分离,强迫症定植小鼠mPFC神经元形态与功能受损并伴mPFC和结肠炎症。血清和mPFC代谢组分析发现琥珀酸积累,琥珀酸抑制神经元活动并诱导炎症;二甲基丙二酸抑制琥珀酸氧化可部分改善行为并减轻神经与肠道炎症。

要点

  • 强迫症患者粪便菌群移植可诱导小鼠出现焦虑样和强迫样行为缺陷。
  • 强迫症菌群定植小鼠mPFC神经元形态功能受损,伴mPFC和结肠炎症。
  • 琥珀酸在强迫症定植小鼠血清和mPFC积累,介导菌群-脑-免疫交互。

核心结论

  • 肠道菌群可能通过琥珀酸信号调节小鼠脑功能和行为,经肠-脑交互参与强迫症病理生理,并可能为该病治疗提供新思路。

研究设计与样本

  • 将首发未用药强迫症患者或人口学匹配健康个体的粪便菌群移植给抗生素处理的SPF小鼠。
  • 采用16S rRNA全长测序分析粪便菌群,并对血清和mPFC进行非靶向代谢组学分析。
  • 使用二甲基丙二酸干预以抑制积累琥珀酸的氧化。

主要发现

  • 强迫症菌群定植足以诱导核心行为缺陷,包括异常焦虑样和强迫样行为。
  • 强迫症与对照菌群定植小鼠的粪便菌群明显分离。
  • 强迫症菌群定植小鼠mPFC神经元形态和功能受损,mPFC和结肠出现炎症。
  • 血清和mPFC代谢组分析显示强迫症定植小鼠琥珀酸积累。
  • 琥珀酸抑制神经元活动并诱导结肠和mPFC炎症反应,影响肠道通透性和脑功能。

关键数值与推荐

  • 二甲基丙二酸通过抑制积累琥珀酸的氧化发挥神经保护作用,减轻下游炎症反应和神经元损伤,部分改善强迫症定植小鼠异常行为并减少神经炎症和肠道炎症。

临床怎么用

  • 该研究提示肠-脑-免疫交互和琥珀酸信号可能成为强迫症治疗的新靶点,但证据来自小鼠模型,尚不能直接用于临床决策。

局限性

  • 研究为小鼠粪便菌群移植模型,结论不能直接外推至人类强迫症患者。
  • 原文未报告样本量、效应量、置信区间或P值等具体统计数值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Emerging evidence suggests that the gut microbiota is closely related to psychiatric disorders. However, little is known about the role of the gut microbiota in the development of obsessive-compulsive disorder (OCD). Here, to investigate the contribution of gut microbiota to the pathogenesis of OCD, we transplanted fecal microbiota from first-episode, drug-naive OCD patients or demographically matched healthy individuals into antibiotic-treated specific pathogen-free (SPF) mice and showed that colonization with OCD microbiota is sufficient to induce core behavioral deficits, including abnormal anxiety-like and compulsive-like behaviors. The fecal microbiota was analyzed using 16 S rRNA full-length sequencing, and the results demonstrated a clear separation of the fecal microbiota of mice colonized with OCD and control microbiota. Notably, microbiota from OCD-colonized mice resulted in injured neuronal morphology and function in the mPFC, with inflammation in the mPFC and colon. Unbiased metabolomic analyses of the serum and mPFC region revealed the accumulation of succinic acid (SA) in OCD-colonized mice. SA impeded neuronal activity and induced an inflammatory response in both the colon and mPFC, impacting intestinal permeability and brain function, which act as vital signal mediators in gut microbiota-brain-immune crosstalk. Manipulations of dimethyl malonate (DM) have been reported to exert neuroprotective effects by suppressing the oxidation of accumulated succinic acid, attenuating the downstream inflammatory response and neuronal damage, and can help to partly improve abnormal behavior and reduce neuroinflammation and intestinal inflammation in OCD-colonized mice. We propose that the gut microbiota likely regulates brain function and behaviors in mice via succinic acid signaling, which contributes to the pathophysiology of OCD through gut-brain crosstalk and may provide new insights into the treatment of this disorder.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Zhang YD, Shi DD, Liao BB, et al. Human microbiota from drug-naive patients with obsessive-compulsive disorder drives behavioral symptoms and neuroinflammation via succinic acid in mice. Mol Psychiatry. 2024. PMID: 38273106. doi:10.1038/s41380-024-02424-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。